3 withdrawn. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Withdrawn 3 |
Follow Angiosarcoma: new trials by email Literature Review of Angiosarcoma trials Research Report on Angiosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma Gemcitabine, 9-ING-41, Docetaxel - Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma | Phase 2 | Withdrawn | Brown University | 2022-03-01 | 2021-12-07 | |
| A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas Gemcitabine, Docetaxel, 9-ING-41 - Sarcoma, Soft Tissue Sarcoma | Phase 2 | Withdrawn | Brown University | 2021-09-01 | 2021-07-28 | |
| AGEN2034 & AGEN1884 in Patients With Recurrent, Inoperable Angiosarcoma AGEN2034, AGEN1884 - Angiosarcoma | Phase 2 | Withdrawn | Agenus Inc. | 2021-02-01 | 2022-01-11 |
Hemangiosarcoma (3) · Bone Neoplasms (2) · Dermatofibrosarcoma (2) · Histiocytoma, Malignant Fibrous (2) · Leiomyosarcoma (2) · Liposarcoma (2) · Rhabdomyosarcoma (2) · Sarcoma (2) · Sarcoma, Synovial (2) · Osteosarcoma (1)
Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Connective and Soft Tissue (3) · Neoplasms, Vascular Tissue (3) · Bone Diseases (2) · Fibrosarcoma (2) · Histiocytoma (2) · Musculoskeletal Diseases (2) · Myosarcoma (2) · Neoplasms by Site (2) · Neoplasms, Adipose Tissue (2) · Neoplasms, Connective Tissue (2) · Neoplasms, Fibrous Tissue (2) · Neoplasms, Muscle Tissue (2) · Neoplasms, Bone Tissue (1)
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione (2) · Docetaxel (2) · Gemcitabine (2) · Ipilimumab (1) · balstilimab (1) · spartalizumab (1)
Brown University (2) · Agenus Inc. (1)
United States (2)
Bradley D DeNardo, MD (1) · Bradley DeNardo, MD (1) · Don S Dizon, MD (1) · Galina G Lagos, MD (1)